Form 4 Tracker
Matthew L. Posard

Director · 1 filing · Latest: May 5, 2026

HALOZYME THERAPEUTICS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing